# GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

> **NCT02082496** · PHASE2 · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 50 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT02082496
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-04
- **Final completion:** 2019-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02082496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02082496, "GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02082496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*